The 5 most recent market catalysts affecting $PRVA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 8, 2026
Corporate Catalyst
Neutral
Impact 65
Privia Health Group 13D Filing Shows dam Boehler/Rubicon Founders Report 5.07% Stake In Co, Holding 6.47M Shares, As Of September 1, 2026
The 13D filing reveals that dam Boehler/Rubicon Founders has taken a 5.07% ownership stake in Privia Health Group (PRVA). This matters because a 13D filing typically indicates an a…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
Privia Health Group shares are trading lower. The company affirmed its FY26 sales guidance with its midpoint below estimates.
The headline indicates a direct corporate catalyst impacting Privia Health Group. While the company affirmed its guidance, the fact that the midpoint is below estimates signals tha…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Privia Health Gr Q2 Adj. EPS $0.38 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
Privia Health (PRVA) announced Q2 adjusted EPS of $0.38, vastly exceeding the $0.07 consensus estimate, and sales of $632.6 million, also beating the $599.186 million estimate. Thi…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 95
CORRECTION: Privia Health Gr Q2 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
Privia Health Group (PRVA) announced Q2 adjusted EPS of $0.19, substantially exceeding the $0.07 consensus estimate, and sales of $632.6 million, beating the $599.186 million estim…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 55
Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.422B Est
Privia Health Group filed an 8-K to affirm its fiscal year 2026 sales guidance, keeping it at $2.35 billion to $2.45 billion. This is a routine disclosure, as the company is simply…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.